Loading organizations...
Loading organizations...
Research and development of patented vaccine technology.
TNG Pharmaceuticals has raised $4.6M across 1 funding round.
TNG Pharmaceuticals has raised $4.6M in total across 1 funding round.
TNG Pharmaceuticals has raised $4.6M in total across 1 funding round.
TNG Pharmaceuticals's investors include Yearling Fund, AIM Group, Blue Grass Angels, Commonwealth Seed Capital, Goose Capital, Ogle Foundation, Texas Halo Fund, University of Louisville Foundation.
TNG Pharmaceuticals has raised $4.6M across 1 funding round. Most recently, it raised $4.6M Series A in February 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 6, 2014 | $4.6M Series A | Yearling Fund | AIM Group, Blue Grass Angels, Commonwealth Seed Capital, Goose Capital, Ogle Foundation, Texas Halo Fund, University of Louisville Foundation |